Foresite Capital Management VI as of Sept. 30, 2025
Portfolio Holdings for Foresite Capital Management VI
Foresite Capital Management VI holds 12 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cg Oncology (CGON) | 34.6 | $90M | 2.2M | 40.28 | |
| Rapt Therapeutics (RAPT) | 15.6 | $40M | 1.6M | 25.79 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 12.3 | $32M | 1.3M | 24.25 | |
| Verastem (VSTM) | 8.9 | $23M | 2.6M | 8.83 | |
| Alumis (ALMS) | 6.5 | $17M | 4.2M | 3.99 | |
| Denali Therapeutics (DNLI) | 5.6 | $15M | 1.0M | 14.52 | |
| Corvus Pharmaceuticals (CRVS) | 4.9 | $13M | 1.7M | 7.37 | |
| Akero Therapeutics (AKRO) | 4.5 | $12M | 245k | 47.48 | |
| Kymera Therapeutics (KYMR) | 3.2 | $8.3M | 146k | 56.60 | |
| Hinge Health Cl A (HNGE) | 2.6 | $6.6M | 135k | 49.08 | |
| Avidity Biosciences Ord (RNA) | 0.7 | $1.7M | 40k | 43.57 | |
| CASI Pharmaceuticals Ord Shs (CASI) | 0.6 | $1.6M | 980k | 1.66 |
